BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36706654)

  • 1. Practice variability in the perioperative management of pediatric moyamoya disease in North America.
    Sun LR; Hersh DS; Smith ER; Aldana PR; Jordan LC
    J Stroke Cerebrovasc Dis; 2023 Apr; 32(4):107029. PubMed ID: 36706654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric Moyamoya Revascularization Perioperative Care: A Modified Delphi Study.
    Sun LR; Jordan LC; Smith ER; Aldana PR; Kirschen MP; Guilliams K; Gupta N; Steinberg GK; Fox C; Harrar DB; Lee S; Chung MG; Dirks P; Dlamini N; Maher CO; Lehman LL; Hong SJ; Strahle JM; Pineda JA; Beslow LA; Rasmussen L; Mailo J; Piatt J; Lang SS; Adelson PD; Dewan MC; Mineyko A; McClugage S; Vadivelu S; Dowling MM; Hersh DS
    Neurocrit Care; 2024 Apr; 40(2):587-602. PubMed ID: 37470933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative anemia and perioperative stroke in children with moyamoya.
    Gatti JR; Ahmad SA; Gardner Yelton S; DiGiusto M; Leung D; Xu R; Cohen AR; Gottesman RF; Sun LR
    J Stroke Cerebrovasc Dis; 2024 Jan; 33(1):107476. PubMed ID: 37976795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of antiplatelet therapy during the perioperative period of revascularization surgery for moyamoya disease patients with ischemic onset.
    Nakamura A; Takasu S; Seki Y; Saito R
    Nagoya J Med Sci; 2024 Feb; 86(1):82-90. PubMed ID: 38505724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of postoperative stroke in pediatric moyamoya patients: a standardized perioperative care protocol.
    Judge J; Kappel AD; Isibor C; O'Hara JE; Larson A; Kleinman M; See AP; Lehman LL; Smith ER
    J Neurosurg Pediatr; 2024 Feb; 33(2):185-189. PubMed ID: 37976515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moyamoya syndrome associated with neurofibromatosis Type 1: perioperative and long-term outcome after surgical revascularization.
    Koss M; Scott RM; Irons MB; Smith ER; Ullrich NJ
    J Neurosurg Pediatr; 2013 Apr; 11(4):417-25. PubMed ID: 23373626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative Cerebral Infarction Risk Factors and Postoperative Management of Pediatric Patients with Moyamoya Disease.
    Muraoka S; Araki Y; Kondo G; Kurimoto M; Shiba Y; Uda K; Ota S; Okamoto S; Wakabayashi T
    World Neurosurg; 2018 May; 113():e190-e199. PubMed ID: 29432946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of pediatric moyamoya disease treated by combined direct-indirect revascularization surgery: single institute experience with surgical and perioperative management.
    Rashad S; Fujimura M; Niizuma K; Endo H; Tominaga T
    Neurosurg Rev; 2016 Oct; 39(4):615-23. PubMed ID: 27180559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome.
    Smith ER; McClain CD; Heeney M; Scott RM
    Neurosurg Focus; 2009 Apr; 26(4):E10. PubMed ID: 19335126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous occlusion of the circle of Willis in children: pediatric moyamoya summary with proposed evidence-based practice guidelines. A review.
    Smith ER; Scott RM
    J Neurosurg Pediatr; 2012 Apr; 9(4):353-60. PubMed ID: 22462697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes after revascularization for pediatric moyamoya disease and syndrome: A single-center series.
    Morshed RA; Abla AA; Murph D; Dao JM; Winkler EA; Burkhardt JK; Colao K; Hetts SW; Fullerton HJ; Lawton MT; Gupta N; Fox CK
    J Clin Neurosci; 2020 Sep; 79():137-143. PubMed ID: 33070883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk Factors and Imaging Biomarkers Associated With Perioperative Stroke in Pediatric Moyamoya Arteriopathy.
    Gardner Yelton SE; Gatti J; Adil M; Guryildirim M; Tekes A; Sun LR
    J Child Neurol; 2022 Dec; 37(12-14):963-969. PubMed ID: 36128779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral revascularization surgery reduces cerebrovascular events in children with sickle cell disease and moyamoya syndrome: Results of the stroke in sickle cell revascularization surgery retrospective study.
    Aldana PR; Hanel RA; Piatt J; Han SH; Bansal MM; Schultz C; Gauger C; Pederson JM; Iii JCW; Hulbert ML; Jordan LC; Qureshi A; Garrity K; Robert AP; Hatem A; Stein J; Beydler E; Adelson PD; Greene S; Grabb P; Johnston J; Lang SS; Leonard J; Magge SN; Scott A; Shah S; Smith ER; Smith J; Strahle J; Vadivelu S; Webb J; Wrubel D
    Pediatr Blood Cancer; 2023 Jul; 70(7):e30336. PubMed ID: 37057741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timing of Revascularization in Ischemic Moyamoya Disease: Association of Early Versus Delayed Surgery with Perioperative and Long-Term Outcomes.
    Xu R; Xie ME; Khalifeh J; Feghali J; Yang W; Kim J; Liew J; Tamargo RJ; Huang J
    World Neurosurg; 2022 Oct; 166():e721-e730. PubMed ID: 35931338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individualized Perioperative Blood Pressure Management for Adult Moyamoya Disease: Experience from 186 Consecutive Procedures.
    Li C; Zhang N; Yu S; Xu Y; Yao Y; Zeng M; Li D; Xia C
    J Stroke Cerebrovasc Dis; 2021 Jan; 30(1):105413. PubMed ID: 33160127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of moyamoya syndrome in patients with Noonan syndrome.
    Gupta M; Choudhri OA; Feroze AH; Do HM; Grant GA; Steinberg GK
    J Clin Neurosci; 2016 Jun; 28():107-11. PubMed ID: 26778511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indirect revascularization with the dural inversion technique for pediatric moyamoya disease: 20-year experience.
    Gadgil N; Lam S; Pyarali M; Paldino M; Pan IW; Dauser RC
    J Neurosurg Pediatr; 2018 Nov; 22(5):541-549. PubMed ID: 30117790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes in Patients with Moyamoya Syndrome and Sickle Cell Disease: A Systematic Review.
    Newman S; Boulter JH; Malcolm JG; Pradilla I; Pradilla G
    World Neurosurg; 2020 Mar; 135():165-170. PubMed ID: 31790841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric Moyamoya Biomarkers: Narrowing the Knowledge Gap.
    Lehman LL; Kaseka ML; Stout J; See AP; Pabst L; Sun LR; Hassanein SA; Waak M; Vossough A; Smith ER; Dlamini N
    Semin Pediatr Neurol; 2022 Oct; 43():101002. PubMed ID: 36344019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple Burr-Hole Surgery for the Treatment of Moyamoya Disease and Quasi-Moyamoya Disease in Children: Preliminary Surgical and Imaging Results.
    Mirone G; Cicala D; Meucci C; d'Amico A; Santoro C; Muto M; Cinalli G
    World Neurosurg; 2019 Jul; 127():e843-e855. PubMed ID: 30954732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.